Annual Report and Accounts

The report states that the company generated €92.8m of revenue in 2023, alongside €6.1m of operating profit. It highlights an expanded Medtronic partnership for GI Genius, including a $100 million upfront payment and potential further milestone payments, while Cosmo's share of GI Genius revenue increased by 137%. The report also describes new Winlevi partnerships, Cortiment approval in Japan, and the creation of a Board ESG Committee overseeing ESG matters.